VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,173 | -31.7% | 1,461 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $23,683 | -2.6% | 1,461 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $24,326 | +3.5% | 1,461 | -41.6% | 0.00% | 0.0% |
| Q4 2022 | $23,500 | +235.7% | 2,500 | 0.0% | 0.00% | – |
| Q3 2022 | $7,000 | +600.0% | 2,500 | +1208.9% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 191 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 191 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 191 | +9450.0% | 0.00% | – |
| Q1 2020 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 2 | -98.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 102 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 102 | -1.0% | 0.00% | – |
| Q1 2019 | $1,000 | -80.0% | 103 | -82.8% | 0.00% | – |
| Q4 2018 | $5,000 | +150.0% | 600 | +500.0% | 0.00% | – |
| Q3 2018 | $2,000 | +100.0% | 100 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |